7WCP
IDXX icon

71 West Capital Partners’s Idexx Laboratories IDXX Stock Holding History

71 West Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
1,151
+120
+12% +$67.3K 0.02% 200
2026
Q1 		$579K Buy
1,031
+95
+10% +$60.9K 0.03% 144
2025
Q4 		$633K Buy
+936
New +$637K 0.03% 116

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

71 West Capital Partners's IDXX Position: Q2 2026 in Review

71 West Capital Partners increased its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, buying an estimated $67.3K and bringing the position to 1,151 shares worth $606K. The position accounts for 0.02% of the portfolio, ranked #200.

71 West Capital Partners first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $633K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • 71 West Capital Partners held 1,151 shares of Idexx Laboratories worth $606K as of Q2 2026.
  • 71 West Capital Partners bought 120 Idexx Laboratories shares in Q2 2026, an estimated $67.3K.
  • Idexx Laboratories made up 0.02% of 71 West Capital Partners's portfolio in Q2 2026, its #200 holding.
  • 71 West Capital Partners first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 71 West Capital Partners's Idexx Laboratories position peaked at $633K in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.